[go: up one dir, main page]

ES2168119T3 - Derivados de quinoxalina para el tratamiento de tinnitus. - Google Patents

Derivados de quinoxalina para el tratamiento de tinnitus.

Info

Publication number
ES2168119T3
ES2168119T3 ES96306764T ES96306764T ES2168119T3 ES 2168119 T3 ES2168119 T3 ES 2168119T3 ES 96306764 T ES96306764 T ES 96306764T ES 96306764 T ES96306764 T ES 96306764T ES 2168119 T3 ES2168119 T3 ES 2168119T3
Authority
ES
Spain
Prior art keywords
tinnitus
quinoxaline
derivatives
treatment
sup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96306764T
Other languages
English (en)
Inventor
Steven Bradley Sands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2168119T3 publication Critical patent/ES2168119T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL USO DE UN COMPUESTO DE LA FORMULA (I) O UNA SAL ACEPTABLE FARMACEUTICAMENTE DE LA MISMA, DONDE A ES N O CH Y R{SUP,1} A R{SUP,4} SON SUSTITUTIVOS ESPECIFICADOS PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL TINNITUS.
ES96306764T 1995-10-10 1996-09-18 Derivados de quinoxalina para el tratamiento de tinnitus. Expired - Lifetime ES2168119T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US521795P 1995-10-10 1995-10-10

Publications (1)

Publication Number Publication Date
ES2168119T3 true ES2168119T3 (es) 2002-06-01

Family

ID=21714768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96306764T Expired - Lifetime ES2168119T3 (es) 1995-10-10 1996-09-18 Derivados de quinoxalina para el tratamiento de tinnitus.

Country Status (10)

Country Link
US (1) US5840723A (es)
EP (1) EP0784973B1 (es)
JP (1) JPH09132530A (es)
AT (1) ATE212842T1 (es)
CA (1) CA2187402C (es)
DE (1) DE69619088T2 (es)
DK (1) DK0784973T3 (es)
ES (1) ES2168119T3 (es)
MX (1) MX9604692A (es)
PT (1) PT784973E (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
US6362227B1 (en) * 1999-03-02 2002-03-26 Sepracor, Inc. Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen
US6436449B2 (en) 2000-03-02 2002-08-20 Bo Gidlund Use of a composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542689B1 (en) * 1991-11-15 1998-09-23 Phafag Aktiengesellschaft Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of neuroprotective compositions
ATE171374T1 (de) * 1991-11-15 1998-10-15 Phafag Ag Verwendung von 1-(aminoalkyl)-3-quinoxalin-2-on derivaten zur herstellung von neuroprotektiven mitteln
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
DE69619088T2 (de) 2002-07-11
EP0784973A3 (en) 1999-12-15
EP0784973B1 (en) 2002-02-06
MX9604692A (es) 1998-04-30
DE69619088D1 (de) 2002-03-21
PT784973E (pt) 2002-06-28
EP0784973A2 (en) 1997-07-23
ATE212842T1 (de) 2002-02-15
US5840723A (en) 1998-11-24
CA2187402C (en) 2000-08-08
DK0784973T3 (da) 2002-03-18
JPH09132530A (ja) 1997-05-20
CA2187402A1 (en) 1997-04-11

Similar Documents

Publication Publication Date Title
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
MY117896A (en) Quinazoline derivatives
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
SE9504661D0 (sv) New compounds
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
AP9701041A0 (en) Pyridylpyrrole compounds.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
SE9702564D0 (sv) New compounds
ES2166470T3 (es) Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a.
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
ES2171553T3 (es) Derivados de quinoxalina utiles en terapia.
CO5011066A1 (es) Compuestos de triazina
GR930100090A (el) Μέ?οδος για την παραγωγή αλάτων κλαβουλανικού οξέος.
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
SE9504662D0 (sv) New compounds
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
ATE243683T1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784973

Country of ref document: ES